HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/2009 - 12/2011

Data type

Scientific literature

Keywords

Diagnostic equipment, HIV and AIDS, Health care costs, Health care expenditures

Citation

Authors

Long EF

Journal

PLoS One

Volume

Issue

Pages

e27625

Publication year

2011

Suggested citation

Long EF. HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis. PLoS One. 2011; 6(11): e27625.

DOI

10.1371/journal.pone.0027625

PMID

22110698

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

HIV screening via fourth-generation immunoassay or nucleic acid amplification test in the United States: a cost-effectiveness analysis

Nav